MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
PODD stock logo

PODD

Insulet Corporation

$204.31
-2.73
 (-1.32%)
Exchange:  NASDAQ
Market Cap:  14.383B
Shares Outstanding:  297375
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Healthcare
Industry:  Medical – Devices
   
CEO:  Ashley A. McEvoy
Full Time Employees:  5400
Address: 
100 Nagog Park
Acton
MA
1720
US
Website:  https://www.insulet.com
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Click to read more…

Revenue Segmentation

MARKETSnap
MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2025/05/08 — Q1 quarter 2025

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue1,697,1002,071,6002,708,100
Gross Profit1,159,9001,445,7001,939,900
EBITDA323,600423,700586,900
Operating Income220,000308,900473,800
Net Income206,300418,300247,100

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets2,588,2003,087,7003,190,400
Total Liabilities1,855,5001,876,1001,675,200
Total Stockholders Equity732,7001,211,6001,515,200
Total Debt1,448,8001,422,00018,400
Cash and Cash Equivalents650,700953,400716,100

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow145,700430,300569,300
Capital Expenditure-75,600-124,900-191,600
Free Cash Flow36,500305,400377,700
Net Income206,300418,300247,100
Net Change in Cash14,500249,200-237,300

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)5,884,976.137Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)6,255,210.727Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)6,142,000Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)968,054.708Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)1,028,956.796Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)1,010,334.091Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)987,681.305Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)1,069,532.143Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)1,044,503.594Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)2,566,308.914Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)2,727,760.092Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)2,678,391.379Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)14.530Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)14.880Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)13.740Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)15Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)6Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
2.072B  ?P/S
 (TTM)
: 
5.3
?Net Income
 (TTM)
: 
418.3M  ?P/E
 (TTM)
: 
58.01
?Enterprise Value
 (TTM)
: 
14.676B  ?EV/FCF
 (TTM)
: 
38.86
?Dividend Yield
 (TTM)
: 
0  ?Payout Ratio
 (TTM)
: 
0
?ROE
 (TTM)
: 
0.17  ?ROIC
 (TTM)
: 
0.14
?Net Debt
 (TTM)
: 
468.6M  ?Debt/Equity
 (TTM)
: 
0.69
?P/B
 (TTM)
: 
9.46  ?Current Ratio
 (TTM)
: 
2.78

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
32.12Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MARKETSnap estimates PODD intrinsic value between $60.82 – $120.46 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate PODD Intrinsic Value

Common questions about PODD valuation

Is Insulet Corporation (PODD) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Insulet Corporation (PODD) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is PODD a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether PODD trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is PODD’s P/E ratio?

You can see PODD’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for PODD?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is PODD a good long-term investment?

Whether PODD fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

PODD

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

-1.32
MARKETSnap

Trading Metrics:

Open: 202.84   Previous Close: 207.04
Day Low: 202.52   Day High: 209.33
Year Low: 202.44   Year High: 354.88
Price Avg 50: 240.33   Price Avg 200: 292.87
Volume: 877668   Average Volume: 1.016M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD
17-03-2026 17:28
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD
PODD Investor Alert: Insulet Corp. Potential Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Device Defect: Levi & Korsinsky
25-03-2026 09:00
PODD Investor Alert: Insulet Corp. Potential Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Device Defect: Levi & Korsinsky
Insulet (PODD) is a Top-Ranked Growth Stock: Should You Buy?
03-04-2026 10:46
Insulet (PODD) is a Top-Ranked Growth Stock: Should You Buy?
Insulet Appoints Mike Panos as Chief Commercial Officer
30-03-2026 08:30
Insulet Appoints Mike Panos as Chief Commercial Officer
Beacon Investment Advisory Services Inc. Cuts Position in Insulet Corporation $PODD
30-03-2026 03:34
Beacon Investment Advisory Services Inc. Cuts Position in Insulet Corporation $PODD
PODD Investor Alert: Insulet Corp. Potential Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Misled on Safety: Levi & Korsinsky
18-03-2026 17:28
PODD Investor Alert: Insulet Corp. Potential Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Misled on Safety: Levi & Korsinsky

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States
  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read